A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma.

Zhu, Jianlin; Kuang, Junxi; Yang, Yi; Zhang, Lei; Leng, Bo; She, Risheng; Zou, Ling

Zhu, Jianlin; Kuang, Junxi; Yang, Yi; Zhang, Lei; Leng, Bo; She, Risheng; Zou, Ling.

Afiliação

Zhu J; Dongguan Institute of Clinical Cancer Research, The Tenth Affiliated Hospital of Southern Medical University, China.
Kuang J; Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, The Tenth Affiliated Hospital of Southern Medical University, China.
Yang Y; Department of Cardiovascular Medicine, The Third Affiliated Hospital of Sun Yat-sen University, China.
Zhang L; Department of Emergency, The Tenth Affiliated Hospital of Southern Medical University, China.
Leng B; Dongguan Institute of Clinical Cancer Research, The Tenth Affiliated Hospital of Southern Medical University, China.
She R; Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, The Tenth Affiliated Hospital of Southern Medical University, China.
Zou L; Dongguan Institute of Clinical Cancer Research, The Tenth Affiliated Hospital of Southern Medical University, China.

Mediators Inflamm ; 2023: 6645476, 2023.

Article em En | MEDLINE | ID: mdl-37114236

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/terapia; Prognóstico; Neoplasias Hepáticas/terapia; Imunoterapia; Metiltransferases; RNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google